Target Name: EDC3
NCBI ID: G80153
Review Report on EDC3 Target / Biomarker Content of Review Report on EDC3 Target / Biomarker
EDC3
Other Name(s): enhancer of mRNA decapping 3 | hYjeF_N2-15q23 | Enhancer of mRNA-decapping protein 3 (isoform 1) | YjeF N-terminal domain-containing protein 2 | LSM16 | yjeF domain containing | LSM16 homolog (EDC3, S. cerevisiae) | Enhancer of mRNA decapping 3 homolog (S. cerevisiae), transcript variant 3 | EDC3 variant 3 | EDC3 variant 2 | FLJ31777 | EDC3 variant 1 | Enhancer of mRNA decapping 3, transcript variant 1 | YjeF_N2 | YjeF domain containing | FLJ21128 | yjeF domain-containing protein 1 | Enhancer of mRNA decapping 3 homolog (S. cerevisiae), transcript variant 2 | YjeF domain-containing protein 1 | hYjeF_N2 | YJDC | MRT50 | yjeF N-terminal domain-containing protein 2 | YJEFN2 | Enhancer of mRNA-decapping protein 3 | LSM16 homolog | enhancer of mRNA decapping 3 homolog | EDC3_HUMAN

EDC3: A Non-Coding RNA-Binding Protein Regulating MRNA Stability and Translation

Enhancer of mRNA Decapping 3 (EDC3) is a protein that plays a crucial role in the regulation of gene expression in eukaryotic cells. It belongs to the IMG family of non-coding RNA-binding proteins and is known to enhance the stability and translation efficiency of mRNAs. EDC3 functions by binding to specific mRNAs and enhancing the binding of transcription factors, thereby promoting the translation of RNA into protein.

EDC3 is a key regulator of gene expression and has been implicated in a wide range of cellular processes, including cell growth, differentiation, and apoptosis. It is a potential drug target and has been targeted by researchers for the development of new treatments for various diseases.

One of the defining features of EDC3 is its ability to enhance the stability and translation efficiency of mRNAs. This is accomplished through its ability to interact with specific mRNAs and enhance their stability. EDC3 has been shown to interact with a wide range of mRNAs, including pre-mRNA, post-mRNA, and microRNA (miRNA) species.

EDC3 is also involved in the regulation of translation efficiency by enhancing the interaction between the mRNA and the ribosome. This is accomplished through its ability to interact with the ribosome and enhance its binding to the mRNA. By doing so, EDC3 promotes the formation of stable RNA-protein complexes, which are then translated into protein.

In addition to its role in regulating mRNA stability and translation efficiency, EDC3 is also involved in the regulation of gene expression by controlling the levels of specific mRNAs in the cell. This is accomplished through its ability to interact with regulatory proteins, such as RNA- protein binding proteins (RBP), and enhance their activity.

EDC3 is also involved in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. Research shows that EDC3 is a critical regulator of apoptosis and is involved in the regulation of cell survival and death. This is accomplished through its ability to interact with pro-apoptotic transcription factors, such as p53, and enhance their activity.

In conclusion, EDC3 is a protein that plays a crucial role in the regulation of gene expression in eukaryotic cells. Its ability to enhance the stability and translation efficiency of mRNAs and regulate the levels of specific mRNAs in the cell make it an attractive drug target and a potential therapeutic agent for a wide range of diseases. Further research is needed to fully understand the mechanisms of EDC3 and its potential as a therapeutic agent.

Protein Name: Enhancer Of MRNA Decapping 3

Functions: Binds single-stranded RNA. Involved in the process of mRNA degradation and in the positive regulation of mRNA decapping. May play a role in spermiogenesis and oogenesis

The "EDC3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EDC3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

EDC4 | EDDM3A | EDDM3B | EDEM1 | EDEM2 | EDEM3 | EDF1 | EDIL3 | EDIL3-DT | EDN1 | EDN2 | EDN3 | EDNRA | EDNRB | EDNRB-AS1 | EDRF1 | EDRF1-AS1 | EDRF1-DT | EEA1 | EED | EEF1A1 | EEF1A1P11 | EEF1A1P14 | EEF1A1P19 | EEF1A1P22 | EEF1A1P25 | EEF1A1P28 | EEF1A1P3 | EEF1A1P30 | EEF1A1P38 | EEF1A1P44 | EEF1A1P47 | EEF1A1P5 | EEF1A1P6 | EEF1A1P9 | EEF1A2 | EEF1AKMT1 | EEF1AKMT2 | EEF1AKMT3 | EEF1AKMT4 | EEF1B2 | EEF1B2P1 | EEF1B2P3 | EEF1B2P5 | EEF1B2P6 | EEF1D | EEF1DP1 | EEF1DP3 | EEF1E1 | EEF1E1-BLOC1S5 | EEF1G | EEF1GP2 | EEF1GP8 | EEF2 | EEF2K | EEF2KMT | EEFSEC | EEIG1 | EEIG2 | EEPD1 | EFCAB10 | EFCAB11 | EFCAB12 | EFCAB13 | EFCAB13-DT | EFCAB14 | EFCAB2 | EFCAB3 | EFCAB5 | EFCAB6 | EFCAB6-AS1 | EFCAB7 | EFCAB8 | EFCAB9 | EFCC1 | EFEMP1 | EFEMP2 | EFHB | EFHC1 | EFHC2 | EFHD1 | EFHD2 | EFL1 | EFL1P1 | EFNA1 | EFNA2 | EFNA3 | EFNA4 | EFNA5 | EFNB1 | EFNB2 | EFNB3 | EFR3A | EFR3B | EFS | EFTUD2 | EGF | EGFEM1P | EGFL6 | EGFL7